je.st
news
Convergence considers IPO after GSK spin-off, as European biotech revives
2014-06-16 13:57:14| Biotech - Topix.net
Convergence Pharmaceuticals, a specialist pain drug company spun off from GlaxoSmithKline, is preparing for a possible stock market listing as British biotech companies enjoy a revival of interest from investors.
Tags: european
considers
ipo
biotech
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||